About the Event
The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professionals in gene and cell therapy. The meeting is the best place for people in the field to learn from the latest scientific research, stay up to date on new technologies, and make career-advancing connections with peers.
Weiheng Su, Head of AAV at OXGENE will be presenting “Discover TESSA® Technology for Scalable, Versatile, Economical AAV Manufacture”.
We will also have a team exhibiting and presenting posters on the following topics:
Weiheng Su – Advancing Recombinant AAV Manufacturing: TESSA® Platform for Scalable and Efficient Gene Therapy Production.
Qian Liu – “Lentiviral Vector Cargo Gene Silencing During Manufacturing” and “Lentiviral Vector Packaging and Producer Cell Lines Yield Titres Equivalent to the Industry-Standard Four-Plasmid Process”.
Contact us to schedule time to meet.